Open access
Research Article
6 February 2018

Prevalence of Infection-Competent Serogroup 6 Legionella pneumophila within Premise Plumbing in Southeast Michigan

ABSTRACT

Coinciding with major changes to its municipal water system, Flint, MI, endured Legionnaires’ disease outbreaks in 2014 and 2015. By sampling premise plumbing in Flint in the fall of 2016, we found that 12% of homes harbored legionellae, a frequency similar to that in residences in neighboring areas. To evaluate the genetic diversity of Legionella pneumophila in Southeast Michigan, we determined the sequence type (ST) and serogroup (SG) of the 18 residential isolates from Flint and Detroit, MI, and the 33 clinical isolates submitted by hospitals in three area counties in 2013 to 2016. Common to one environmental and four clinical samples were strains of L. pneumophila SG1 and ST1, the most prevalent ST worldwide. Among the Flint premise plumbing isolates, 14 of 16 strains were of ST367 and ST461, two closely related SG6 strain types isolated previously from patients and corresponding environmental samples. Each of the representative SG1 clinical strains and SG6 environmental isolates from Southeast Michigan infected and survived within macrophage cultures at least as well as a virulent laboratory strain, as judged by microscopy and by enumerating CFU. Likewise, 72 h after infection, the yield of viable-cell counts increased >100-fold for each of the representative SG1 clinical isolates, Flint premise plumbing SG6 ST367 and -461 isolates, and two Detroit residential isolates. We verified by immunostaining that SG1-specific antibody does not cross-react with the SG6 L. pneumophila environmental strains. Because the widely used urinary antigen diagnostic test does not readily detect non-SG1 L. pneumophila, Legionnaires’ disease caused by SG6 L. pneumophila is likely underreported worldwide.
IMPORTANCE L. pneumophila is the leading cause of disease outbreaks associated with drinking water in the United States. Compared to what is known of the established risks of colonization within hospitals and hotels, relatively little is known about residential exposure to L. pneumophila. One year after two outbreaks of Legionnaires’ disease in Genesee County, MI, that coincided with damage to the Flint municipal water system, our multidisciplinary team launched an environmental surveillance and laboratory research campaign aimed at informing risk management strategies to provide safe public water supplies. The most prevalent L. pneumophila strains isolated from residential plumbing were closely related strains of SG6. In laboratory tests of virulence, the SG6 environmental isolates resembled SG1 clinical strains, yet they are not readily detected by the common diagnostic urinary antigen test, which is specific for SG1. Therefore, our study complements the existing epidemiological literature indicating that Legionnaires’ disease due to non-SG1 strains is underreported around the globe.

INTRODUCTION

The leading cause of disease due to drinking water in the United States is Legionella pneumophila (1). This bacterium naturally resides in fresh water, but the majority of Legionnaires’ disease cases originate in engineered water systems. People become infected with legionellae by inhaling contaminated aerosols generated by devices that release water vapors, such as cooling towers, hot tubs, whirlpools, decorative fountains, and showers (2). Older adults with underlying disease, immunosuppression, or a history of smoking are especially vulnerable to Legionnaires’ disease, a severe, sometimes fatal, pneumonia (3). For reasons not understood, the incidence of Legionnaires’ disease increased 3-fold from 2000 to 2011 across the United States and all age groups (1, 3, 4). Likewise, the cases reported in Europe tripled during the 1995–2014 period (5).
Clinicians typically treat community-acquired pneumonia empirically and promptly with broad-spectrum antibiotics to forgo the expense and time required for specific diagnosis (3, 6). When the infectious agent is sought, the most common diagnostic tool for Legionnaires’ disease is the urinary antigen test, a rapid low-cost assay specific for L. pneumophila of serogroup 1 (SG1) (7). Although this pathogenic type of legionellae is associated with >80% of Legionnaires’ disease cases worldwide, >60 species and 16 serogroups exist, half of which have been isolated from patients (8). Disease due to non-SG1 L. pneumophila is likely underreported, since in the United States and Europe >75% of Legionnaires’ disease cases are diagnosed by the urinary antigen test and just ~5% are confirmed by culture (8, 9). Indeed, it is estimated that only ~5% of Legionnaires’ disease cases in the United States are reported (10). Although widespread reliance on the urinary antigen test and empirical broad-spectrum antibiotic treatment are efficient and cost-effective for most patients, these clinical practices hamper not only identification of other pathogenic legionellae but also epidemiological investigations to track and eliminate the source of Legionnaires’ disease outbreaks.
Especially prone to colonization by L. pneumophila are hospitals and hotels, due to their warm temperatures, large size, and multiple partitions with irregular usage that create areas with low or no flow (11). Stagnant water favors growth of biofilms, adherent microbial communities that are difficult to eradicate (3, 12). L. pneumophila also survives and replicates within predatory free-living protozoa that graze on biofilms (11). Extermination of legionellae residing within protozoa or biofilms requires elevated doses of disinfectants (1317). Consequently, despite remediation efforts, L. pneumophila can persist in complex engineered water systems and cause recurrent disease outbreaks for decades (1823). Indeed, despite infection control measures, L. pneumophila was found to colonize 70% of Pittsburgh and 60% of Paris hospital water systems surveyed (24, 25).
Compared to our knowledge of the established risks of legionella colonization within large buildings, relatively little is known about exposure within single-family homes and low-rise housing units. Based on limited sample sizes, the prevalence of residences whose water is culture positive for legionellae has been reported to be 6 to 30% (2631). L. pneumophila colonization can be suppressed by maintaining a chlorine concentration of >2 mg/liter (32, 33). However, hot water residential lines often contain little measurable levels of chlorine, due to its decay at elevated temperatures (32). Since only 4% of the Legionnaires’ disease cases reported in the United States from 2000 to 2009 were associated with outbreaks (4), sporadic or epidemiologically unrelated cases of Legionnaires’ disease due to colonization of the built environment by legionellae may be more insidious and widespread than currently documented.
In the summers of 2014 and 2015, Genesee County, MI, endured outbreaks of Legionnaires’ disease (26). Compounding the anxiety within the community, the 87 confirmed cases of disease occurred during a period of sustained damage to the municipal water system of Flint, the county’s largest city (27). When the anticorrosive agent orthophosphate was omitted from the Flint water supply, toxic lead leached from pipes and fixtures into the municipal water. The impact of the water’s altered physiochemistry on the burden, resilience, or virulence of the microbial communities in the Flint water system is an open question.
To inform the rational design of risk management strategies to keep public water supplies safe, the State of Michigan supported the Flint Area Community Health and Environment Partnership (FACHEP) research team’s analysis of legionellae within the Flint municipal system. Working closely with local health care providers, community organizations, and government agencies, we applied a multidisciplinary strategy that integrated environmental monitoring and water testing with clinical education, molecular epidemiology, and laboratory assays of L. pneumophila virulence. Here we present our laboratory analysis of the genetic diversity and virulence potential of L. pneumophila isolated from Flint premise plumbing in the fall of 2016.

RESULTS

Legionella screening in Flint, MI, and neighboring census tracts.

To determine the prevalence of legionellae in Flint premise plumbing, a random sample of Flint’s households was surveyed from 6 September to 29 October 2016, 1 year after the 2015 summer outbreak. In Southeast Michigan, this period corresponds to the end of the typical Legionnaires’ disease season, which peaks annually during warm-weather months. From 130 residences, water samples were collected from the kitchen faucet, shower, and hot water heater and then cultured to isolate viable legionellae. Overall, L. pneumophila was cultured from 13 Flint and 2 Detroit residences (data not shown). Water samples from two other Flint residences contained non-pneumophila legionellae; these strains were not analyzed further. In one home, L. pneumophila was isolated from the hot water heater, shower, and kitchen faucet; in another residence, a positive culture was obtained from the shower and another from the kitchen faucet (Table 1). In total, we obtained a single L. pneumophila isolate from each of 16 positive premise plumbing samples from 13 Flint residences and a single L. pneumophila isolate from each of 2 premise plumbing sites in two Detroit residences (Fig. 1; Table 1). A similar incidence of culture-positive premise plumbing was obtained in Flint and non-Flint residences; however, the small sample size of non-Flint residences precludes statistical tests of significance. Of the hot water heaters that were sampled and noted, 125 were gas and only 1 was electric; therefore, our residential survey cannot address whether hot water heater design contributed to the risk of premise plumbing colonization by L. pneumophila, as reported previously (28).
TABLE 1 
TABLE 1 Southeast Michigan environmental and clinical isolates analyzeda
StrainSourceSero-
group
Clonal
complex
Sequence
type
No. of isolates containing:CitySite or
references
flaApilEasdmipmompSproAneuA
EF1Environ6E367610152821149FlintKitchen faucet
EF2Environ6E367610152821149FlintShower (A)
EF3Environ6E367610152821149FlintHot water heater (A)
EF23Environ6E367610152821149FlintKitchen faucet (A)
EF4Environ6E367610152821149FlintKitchen faucet
EF5Environ6E367610152821149FlintKitchen faucet
EF6Environ6E367610152821149FlintKitchen faucet
EF7Environ6E367610152821149FlintHot water heater
EF8Environ6E367610152821149FlintHot water heater
EF16Environ6E367610152821149FlintHot water heater
ED20Environ6E367610152821149DetroitShower
EF22Environ6E367610152821149FlintKitchen faucet
EF11Environ6E461610142821149FlintKitchen faucet (B)
EF13Environ6E461610142821149FlintShower (B)
EF14Environ6E461610142821149FlintShower
EF15Environ6E461610142821149FlintHot water heater
ED21Environ1 7775222106251DetroitShower
EF10Environ1D11431111FlintShower
C45Clinic1D11431111  
C51Clinic1D11431111  
C52Clinic1D11431111  
C53Clinic1D11431111  
C24Clinic1A22221951018110  
C25Clinic1A22221951018110  
C30Clinic1A22221951018110  
C32Clinic1A22221951018110  
C34Clinic1A22221951018110  
C35Clinic1A22221951018110  
C36Clinic1A22221951018110  
C38Clinic1A22221951018110  
C41Clinic1A22221951018110  
C44Clinic1A22221951018110  
C29Clinic1A2132195101812  
C31Clinic1A2132195101812  
C40Clinic1A2132195101812  
C43Clinic1A2132195101812  
C46Clinic1A2132195101812  
C47Clinic1A2132195101812  
C42Clinic1A2132195101812  
C49Clinic1B9412811520122  
C27Clinic1B1941128111520122  
C37Clinic1B1941128111520122  
C54Clinic1B1941128111520122  
C39Clinic1B4448111010122  
C26Clinic1C83081031018110  
C28Clinic1C19838103153316  
C48Clinic1C628103151816  
C56Clinic1C231810315211220  
C33Clinic1 4551222661012  
C50Clinic1 10002121416115132  
C55Clinic1 2113101114911  
Lp01Lab1 3634111491  
Lp02Lab1 3634111491  
ME4774Environ6E367       Murcia
(Spain)
37, 38
a
A boldface strain number indicates that it was selected for phenotypic analysis. Sites with the same parenthetical letter after them indicate that the samples came from the same residence. Environ, environment.
FIG 1 
FIG 1 Geographic distribution of Legionella screening in Flint and neighboring census tracts. From 6 September through 29 October 2016, water samples were collected from the kitchen faucet, shower, and hot water heaters of 187 residences and processed to isolate viable Legionella spp. The number of sites sampled in each census tract is indicated (heat map). The sites where Legionella spp. were detected are indicated (green circles), with random offset within the census tract to protect residents’ privacy. The region serviced by the Flint municipal water supply is delineated (blue line).

Phylogenetic analysis of Southeast Michigan clinical and environmental L. pneumophila isolates.

To gain insight into the genetic diversity of the L. pneumophila strains obtained from premise plumbing in Flint in the fall of 2016, we determined the phylogenetic relationships among the 18 environmental isolates. In parallel, we also analyzed 33 clinical isolates that hospitals in three Southeast Michigan counties (Genesee, Wayne, and Oakland) submitted to the Michigan Department of Health and Human Services Bureau of Laboratories from 2013 to 2016 (Table 1). We first applied a DNA sequence-based typing (SBT) scheme that is standard practice in the international Legionella community (29). Using the DNA sequences of seven chromosomal alleles, SBT can discriminate among more than 2,000 different sequence types (STs) of L. pneumophila strains present worldwide, increasing the power of outbreak investigations (18). To identify related genotypes within the typed environmental and clinical L. pneumophila isolates from Southeast Michigan, we applied the eBURST algorithm (30). We defined a clonal complex as those strains that shared at least four of seven typing alleles with at least one other member of the group.
Among the L. pneumophila strains isolated from patients in Southeast Michigan in 2013 to 2016, four phylogenetic clusters were evident, as judged by SBT and eBURST analysis. Of the 33 clinical isolates, 30 (91%) belonged to one of these four clonal complexes (Fig. 2). The largest group included 17 clinical isolates of the closely related ST222 and ST213, which differ at just one of the seven typing alleles. In the United States from 1982 to 2012, ST222 was among the most prevalent STs of both sporadic and outbreak-associated L. pneumophila SG1 isolates (18). The next-largest clinical cluster had five members of three related STs (ST1941, ST94, and ST44); a third cluster had four members, each of which was a singleton ST (ST231, ST1983, ST62, ST830). Four clinical isolates and one Flint environmental isolate were of ST1, the most common sporadic ST in the United States during the 1982–2012 period (18).
FIG 2 
FIG 2 Phylogenetic relationship between Southeast Michigan clinical and environmental L. pneumophila isolates. The sequence types of 18 environmental isolates collected in the fall of 2016 and of 33 clinical isolates submitted to the MDHHS Bureau of Laboratories from Genesee, Wayne, and Oakland County hospitals in 2013 to 2016 were determined and their relationships identified by eBURST analysis. The number of isolates of each ST is indicated by the size of each filled black circle and is stated in parentheses if it is >1; the isolates’ origins (boxed) are also indicated. Clonal complexes (circled) were defined as members of an ST that shared at least four of the seven typing alleles with at least one other member of the group; superscripts refer to the complex designation in Table 1. The scale bar indicates the distance separating isolates that differ at one of the seven typing alleles.
The majority of the L. pneumophila strains isolated from Flint premise plumbing in the fall of 2016 were closely related genetically. Of the 16 Flint strains, 15 (94%) formed a distinct clonal complex comprised of ST367 and ST461, which are identical at six of the seven typing loci. One of the Detroit premise plumbing isolates was also ST367; the other was a genetically distinct strain of ST777. Thus, compared to the 33 Southeast Michigan clinical isolates obtained during 2013 to 2016, the 18 L. pneumophila strains isolated from Flint and Detroit premise plumbing in the fall of 2016 were less genetically diverse, and only one environmental strain had an ST in common with the clinical strains.

SG1 and SG6 L. pneumophila isolates verified by immunofluorescence microscopy.

ST367 and -461 strains have been isolated previously from both patients and environmental surveillance operations during outbreaks in Poland, Israel, and Spain (3133). Notably, these ST367 and -461 L. pneumophila strains were demonstrated to be of SG6. To determine whether the 16 Southeast Michigan premise plumbing L. pneumophila ST367 and -461 isolates were also of SG6, serotype-specific antibodies were used to perform immunocytochemistry (Pathogen Control Associates, Peachtree Corners, GA [data not shown]) and immunofluorescence microscopy. As expected, each of the ST367 and -461 L. pneumophila isolates from Flint and Detroit residences reacted with an SG6-specific antibody, whereas none cross-reacted with an antibody specific to SG1 antigens (Fig. 3 and data not shown).
FIG 3 
FIG 3 Serogroup 1 and serogroup 6 L. pneumophila isolates distinguished by immunofluorescence microscopy. Serogroup designations for clinical and environmental isolates, determined by clinical and commercial laboratories, respectively, were verified by immunolocalization of cell-associated bacteria 16 h after inoculation of mouse macrophage cultures using FITC-labeled serotype-specific antibodies. All bacteria and macrophages were visualized by staining their DNA with DAPI (not shown).

Some SG6 L. pneumophila strains are sensitive to human serum.

L. pneumophila serotyping is based on the structure of its lipopolysaccharide (LPS) O antigen, a feature of the outer membrane that also affects complement-mediated killing. Serogroup 1 L. pneumophila strains are resistant to killing by complement in human serum (34), whereas the serogroup 6 L. pneumophila Thunder Bay strain is sensitive, as judged by direct binding of the complement components C3 and C9, as well as decreased bacterial viability (35). To assess whether serogroup or strain origin affected the serum sensitivity of our Southeast Michigan strains, we incubated representative strains in nonimmune human serum or heat-inactivated human serum for 30 min at 37°C and then quantified viability by enumerating CFU. Consistently with the growth phase regulation of its LPS (36), the capacity of L. pneumophila to resist complement-mediated killing was growth phase dependent; serum killed >50% of exponential-phase cells of the serogroup 1 laboratory strains Lp01 and Lp02 but had little effect on the viability of cells cultured to the postexponential (PE) phase (Fig. 4). Complement-mediated killing accounted for most of the toxicity, since heat-treated serum had little effect on the viability of PE-phase bacteria. Although variability between strains and between experiments was observed, a few consistent patterns were noteworthy. Survival of ~90% or more was observed for PE-phase cells of six of the seven clinical serogroup 1 isolates (C53, C32, C35, C46, C43, and C56) and the serogroup 1 premise plumbing isolate from Detroit (ED21). In contrast, three of the five ST367 serogroup 6 strains were serum sensitive: two of these isolates were from Flint premise plumbing (EF2, EF23), and the third (ME4774) was isolated from a water facility during the 2001 outbreak in Murcia, Spain (37, 38). On the other hand, serum resistance was observed for two other ST367 strains (EF6, ED20) and three of the closely related ST461 serogroup 6 strains (EF11, EF14, EF15). Whether genetic differences within the genes encoding the LPS O antigen account for the degrees of serum sensitivity observed among and between the serogroup 1 and serogroup 6 strains analyzed here can be evaluated by genome sequencing.
FIG 4 
FIG 4 Sensitivities of serogroup 1 and serogroup 6 L. pneumophila isolates to human serum. The capacities of representative laboratory strains (Lp02, Lp01), clinical strains (“C” followed by a number), and environmental strains from Flint (“EF” followed by a number), Detroit (“ED” followed by a number), and Murcia, Spain (ME4774), to survive treatment with 90% human serum without (black circles) and with (gray circles) heat inactivation of complement were quantified by enumerating CFU before and after the 90- to 120-min incubation at 37°C. Shown are the means (solid or dotted horizontal lines) calculated in 2 to 4 independent experiments ± SD. Brackets indicate STs within clonal complex A or E (subscripts). For all strains, PE-phase cells were analyzed. Where indicated, exponential-phase cells (E) were also studied.

Both SG1 and SG6 L. pneumophila isolates infect macrophages efficiently.

According to an analysis of 3254 Legionnaires’ disease cases from 1980 to 1989 (39), mortality after infection with SG6 L. pneumophila exceeds that caused by SG1 strains (63% versus 37%, respectively). To cause disease, L. pneumophila survives and replicates within macrophages (40). Therefore, as a first step to gauge the virulence of the SG6 L. pneumophila strains isolated from Southeast Michigan premise plumbing, their capacity to survive ingestion by macrophages was quantified.
Macrophages derived from mouse bone marrow were infected for 1 h with representative clinical (C) and environmental (EF, from Flint; ED, from Detroit) isolates, fixed, and labeled with serotype-specific anti-L. pneumophila antibodies, and their DNA was stained. The infected macrophages were then examined by fluorescence microscopy. As expected, 95% of cell-associated PE-phase cells of L. pneumophila laboratory strain Lp02 remained as intact rods, whereas nearly 60% of the exponential-phase bacteria were degraded by macrophages (Fig. 5A) (41). As with the virulent PE-phase Lp02 control bacteria, for each of the clinical SG1 L. pneumophila strains, whether of ST1, ST213, or ST222, >85% of the PE-phase bacteria associated with macrophages remained rod shaped after a 1-h incubation. Likewise, >90% of the inocula of either SG1 or SG6 environmental strains of L. pneumophila evaded digestion by macrophages. The capacities to avoid degradation were similar for environmental strains of ST1, ST367, and ST461, as well as for isolates obtained from Flint and Detroit premise plumbing.
FIG 5 
FIG 5 Survival of serogroup 1 and serogroup 6 L. pneumophila isolates 1 h after inoculation of macrophage cultures. (A) The capacity of representative clinical isolates (“C” followed by a number, white bars) and environmental isolates (light-gray bars) from Flint (“EF” followed by a number) and Detroit (“ED” followed by a number) to avoid degradation within mouse macrophages 1 h after infection with PE cells was determined by fluorescence microscopy using serotype-specific antibodies and PE- and exponential-phase cells (E) of strain Lp02 as positive and negative controls (dark-gray bars), respectively. Shown are means ± SD calculated from triplicate cell preparations from which at least 100 bacteria were scored as either rod or non-rod shaped. The data are representative of at least two independent experiments. (B) The capacity of each isolate indicated to bind to and survive on or within macrophages was determined for PE-phase cells by enumerating cell-associated CFU 1 h after inoculation of macrophage cultures. PE-phase wild-type Lp02 and dotA mutant cells served as positive and negative controls, respectively. Shown are means ± standard errors (SE) calculated from triplicate cell cultures. The origin, sequence type, and serogroup of each strain are indicated. One-way analysis of variance was calculated by comparing each strain to the WT laboratory strain: *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. The means for the two ST461 and four ST367 strains were compared using Welch’s t test (**, P < 0.01).
As a more rigorous test of infectivity, the capacity of representative clinical and environmental isolates to survive on or within macrophages was determined by enumerating cell-associated CFU 1 h after inoculation of the cultures. Four of the five clinical SG1 L. pneumophila strains survived their initial interaction with macrophages as well as or better than did the laboratory wild-type (WT) control strain (Fig. 5B). For example, 24% of the inoculum of the virulent PE-phase WT laboratory strain was cell associated and viable 1 h after addition to cultured macrophages, compared to 33 to 51% of the SG1 ST213 and ST222 clinical strains. Likewise, 1 h after infection, four of the environmental strains infected macrophages more efficiently than did the WT laboratory strain; 35 to 58% of the inoculum was viable and cell associated for the ST1 and ST777 SG1 strains and for both ST461 SG6 strains. Compared to ST461 strains, ST367 SG6 strains infected macrophages less efficiently (P < 0.01), with the infective cells ranging from 16 to 30% of each inoculum, a rate similar to that of the WT laboratory control strain. The single Detroit ST367 isolate (ED20) infected macrophages at a frequency similar to that of the three ST367 strains from Flint (EF1, EF3, and EF16). Thus, as judged by both direct and viable-cell-count assays, the clinical and environmental strains were competent to infect cultured mouse macrophages.

SG1 and SG6 L. pneumophila isolates each replicate efficiently in macrophages.

The capacity of the environmental and clinical isolates to replicate within macrophages was first evaluated by microscopy. Infected macrophages were incubated for 20 h, fixed, and labeled with serotype-specific antibodies, and their DNA was stained. The WT laboratory strain replicated profusely during the primary infection period, unlike the negative-control strain, an avirulent dotA mutant (Fig. 6A). Likewise, numerous L. pneumophila progeny were visible within macrophages infected for 20 h with either of two different SG1 ST1 isolates, whether obtained from a patient (strain C45) or Flint premise plumbing (strain EF10). A similar pattern was observed for two SG1 ST213 clinical strains and representative SG6 ST461 and ST367 environmental strains.
FIG 6 
FIG 6 Yields of serogroup 1 clinical and serogroup 6 environmental isolates of L. pneumophila after infection of cultured macrophages. (A) Representative images of macrophages infected for 20 h with the indicated clinical isolates (“C” followed by a number) and environmental isolates from Flint (“EF” followed by a number) and Detroit (“ED” followed by a number) of the serogroup and sequence type shown and then fixed and stained with FITC-labeled and serotype-specific antibodies. PE-phase Lp01 L. pneumophila served as the positive control at both 1 and 20 h; the negative control was dotA mutant bacteria after 20 h. All bacteria and macrophages were visualized by staining their DNA with DAPI (not shown). Similar patterns were observed in two other independent experiments. (B) The capacity of representative clinical and environmental isolates from Flint and Detroit to replicate in mouse macrophages was quantified by enumerating total CFU per sample 1, 24, 48, and 72 h after infection. Shown are means calculated from duplicate or triplicate samples at each time indicated, divided by the mean cell-associated CFU 1 h after infection. Error bars indicate SD. One-way analysis of variance was calculated by comparing the maximum yield of each strain to that of the WT laboratory strain: **, P < 0.01; ****, P < 0.0001. Similar results were obtained in two additional independent experiments, with the exception of C53, which was analyzed twice.
To quantify L. pneumophila intracellular replication, CFU were enumerated 1, 24, 48, and 72 h after infection of mouse macrophages. During the 72-h infection period, the yield of each of the SG1 clinical strains, whether of ST213, ST222, or ST1, increased 120- to 850-fold (Fig. 6B). Some strain-to-strain variation was apparent; for example, the yield of the two ST1 isolates increased 150- and 120-fold, whereas that of the two ST213 isolates increased 650- and 850-fold. Similarly, the number of CFU increased by >100 for six of the eight environmental strains analyzed, a group that included strains of SG1 ST1 and -777 and SG6 ST461 and -367. A more modest ~50-fold increase in the number of CFU was observed for two strains (EF14 [SG6 ST461] and EF3 [SG6 ST367]). It was curious that seven of the eight environmental L. pneumophila strains achieved their maximal yield in CFU at 48 h, whereas two of the five clinical isolates and the laboratory strain did so at 72 h. Whether alterations to the bacteria and/or macrophages contribute to this kinetic difference requires more detailed analysis. Overall, regardless of their SG, ST, or origin in Flint or Detroit, each of the clinical and the environmental L. pneumophila isolates from Southeast Michigan had the capacity to infect, survive in, and replicate within cultured mouse macrophages, laboratory indicators of the potential to cause disease.

DISCUSSION

Using a multidisciplinary approach coordinated with local partner health care providers, community organizations, and government agencies, the Flint Area Community Health and Environment Partnership (FACHEP) research team investigated the presence of L. pneumophila in Flint’s premise plumbing 1 year after Legionnaires’ disease outbreaks in two consecutive summers that coincided with the Flint water crisis. To do so, we integrated environmental monitoring and water testing with clinical education, assessment of social needs and resilience, population-based and molecular epidemiological surveillance, and laboratory assessments of virulence. In the molecular and phenotypic analysis of L. pneumophila strains isolated in Southeast Michigan reported here, we found little genetic overlap between the environmental and the clinical strains. All 33 clinical isolates are of SG1, consistent with the widespread use, both in Southeast Michigan and globally, of diagnostic tests that are specific to serogroup 1 L. pneumophila. In contrast, only two of the 18 premise plumbing isolates are SG1 strains. Instead, 89% of the 18 household strains are SG6 L. pneumophila of ST367 and ST416, two closely related STs. The virulence of the SG6 strains isolated from premise plumbing in Flint and Detroit resembles that of the SG1 clinical strains, as judged by their capacity to infect and replicate in cultured macrophages, a hallmark of L. pneumophila pathogenesis. As expected, SG6 L. pneumophila ST367 and -461 strains did not bind an SG1-specific antibody (Fig. 3). Since the widely applied diagnostic urinary antigen tests also rely on serotype-specific antibodies, it is likely that SG6 strains are not readily detected (42).
Across the globe, the most widespread L. pneumophila strains are SG1 ST1 strains. In China, SG1 ST1 strains represented 49% of the 164 L. pneumophila isolates collected from natural and engineered water supplies from 2005 to 2012 (43). Likewise, a U.S. survey analyzing 571 sporadic SG1 clinical isolates and 149 environmental isolates unrelated to disease cases that were collected from 1982 to 2012 found that ST1 L. pneumophila isolates were not only of the most prevalent serogroup (SG1) in both potable and nonpotable water (49% of all samples) but also the most frequent cause of sporadic Legionnaires’ disease (25% of cases) (18). Of the 4,785 clinical strains submitted from Europe to the EWGLI database, 10% are of ST1 (44). In France from 2008 to 2012, SG1 ST1 strains represented 21% of environmental isolates and 9.1% of clinical cultures yet accounted for 31% of nosocomial cases of Legionnaires’ disease (45). In a 2000–2008 surveillance study in England and Wales, L. pneumophila was cultured from 3.2% of samples collected from premise plumbing (46). Compared to 167 isolates from unrelated clinical cases, there was very little genetic overlap, as judged by ST (P < 0.0001). The only exception was SG1 ST1 strains, which comprised 20% of the premise plumbing isolates and 4.8% of the patient isolates (46). Likewise, in Southeast Michigan, SG1 ST1 was the only strain type isolated from both premise plumbing (1 of 18 samples; 5.6%) and patients (4 of 33 patients; 12%) (Fig. 2). Analysis of the whole-genome sequences of 229 L. pneumophila ST1 isolates from community- and hospital-acquired cases of Legionnaires’ disease and from water systems of the corresponding hospitals determined that ascribing an epidemiological link between ST1 strains requires a combination of molecular genetic and clinical epidemiological data, because levels of genetic diversity and stability differ across locations, and L. pneumophila spreads internationally (47). The molecular mechanisms and epidemiological processes that contribute to SG1 ST1 L. pneumophila prevalence worldwide remain to be understood.
Among the 33 SG1 clinical isolates collected in Southeast Michigan from 2013 to 2016, the majority belonged to one of four clonal complexes (Fig. 2). None of these clinical isolates were of ST35, ST36, or ST37, three strain types that caused a total of 10 outbreaks and 64 sporadic disease cases in the United States during 1982 to 2012 (18). In Southeast Michigan from 2013 to 2016, the largest clonal complex of clinical isolates included strains of ST222 and ST213, which are identical at six of the seven typing loci. In the United States from 1982 to 2012, L. pneumophila ST222 strains were among those most frequently associated with outbreaks, and strains of ST222 and ST213 were often associated with sporadic cases of Legionnaires’ disease (18). The ST222 genetic lineage has been prevalent in the northeastern regions of the United States and Canada but rare elsewhere (18, 48). After emerging in Ontario in 1999, over the next 8 years, ST222 L. pneumophila strains comprised 11 to 15% of clinical isolates in this Canadian province, including those responsible for the large 2005 outbreak at a long-term-care facility (48). The 2012 Calgary, Canada, outbreak of eight Legionnaires’ disease cases is an interesting exception, as it occurred during winter months with temperatures between 7°C and −26°C (49). Although environmental surveillance did not identify the reservoir, epidemiological and genome sequencing data predicted a likely point source: water contaminated with L. pneumophila of ST222 sprayed to extinguish fires or to minimize dust at construction sites in this city in western Canada (49).
It is possible that SG6 strains of L. pneumophila are endemic in the Great Lakes region. Of the 18 environmental isolates obtained in the fall of 2016 from Flint and Detroit premise plumbing, 89% were SG6 L. pneumophila strains. Among these, strains of the same ST, ST367, were isolated from 11 premise plumbing sites in Flint and one residence in Detroit, which did not receive treated Flint River water in 2014 to 2015. A 1981 survey of 52 sites in the Great Lakes, which border Michigan, yielded only two L. pneumophila strains, but both were of SG6 (50). In a 1984 analysis of water from 31 buildings in Ontario, a Canadian province adjacent to Southeast Michigan, SG6 strains were isolated slightly more frequently (12 of 19 buildings) than SG1 L. pneumophila strains (10 of 19 buildings). Elsewhere, SG6 strains are also prevalent. In the water distribution systems of nine hospitals in Poland, SG6 strains comprised 33% of the 11 environmental isolates, whereas SG1 strains accounted for 24% (31). In the Attica region of Greece, SG6 strains represented 62% of 37 L. pneumophila environmental isolates (51). In contrast, SG6 strains comprised only 15% of the L. pneumophila strains collected in England and Wales (46) and 11% of those isolated in France (52). More extensive surveillance studies can determine whether the predominance of SG6 L. pneumophila strains observed in Flint in the fall of 2016 is typical of the Great Lakes region or instead reflects a microbial response to the altered physiochemistry of the Flint municipal water system during 2014 and 2015. Another factor that might contribute to the predominance of SG6 strains in surveillance studies is L. pneumophila’s capacity to differentiate into a viable-but-nonculturable state. By this model, if, compared to other legionellae, SG6 strains are more readily cultured from water samples, their apparent prevalence would be elevated. Whether exposure to corrosive water characteristic of the 2014–2015 Flint water crisis alters the culturability, resilience, or virulence of L. pneumophila is one focus of ongoing analysis.
The genetic homogeneity of the 16 SG6 L. pneumophila strains cultured from Southeast Michigan premise plumbing is also striking: 12 strains are of ST367 and 4 others are of ST461, which share six of seven typing loci (Fig. 2). In contrast, of the 410 SG6 L. pneumophila strains submitted to the EWGLI database, only 5 are of ST367 and 9 are of ST461, and they originated from a variety of countries and continents. Whether the climate or water chemistry in Southeast Michigan contributed to the prevalence of this lineage during the fall of 2016 requires more detailed studies.
Although very few studies have reported sequence type analysis of SG6 L. pneumophila strains, the stability of particular genetic lineages has been suggested. In one hospital in Sweden, SG6 L. pneumophila isolates from three different patients and seven water samples were each of ST1392, as were eight of nine control clinical isolates from unrelated locations (53). In the Attica region of Greece, among 25 SG6 isolates, 28% were of ST68 and 20% were of ST461 (51), a type prevalent in Flint premise plumbing (Fig. 2) and also present in hospital water systems in Poland (31). In contrast, a 2-year surveillance study of a larger territory in Greece identified 10 different STs among 28 SG6 L. pneumophila strains isolated (51). More detailed genetic and phenotypic analyses of SG6 ST367 and ST461 strains from Flint, Detroit, Ontario, and Spain (33, 35) can evaluate whether this L. pneumophila lineage is either endemic to Southeast Michigan, more readily recovered from water samples, or more fit in the physiochemical conditions peculiar to the 2014–2015 Flint municipal water system.
A critical question is whether the SG6 L. pneumophila strains present in premise plumbing in Southeast Michigan put residents at risk. The virulence potential of environmental SG6 L. pneumophila ST367 and ST461 strains was comparable to that of SG1 clinical strains, as judged by quantifying entry, survival, evasion of digestion, and replication within cultured mouse macrophages (Fig. 5 and 6). In Israel, Spain, and Greece, SG6 strains of ST367 and ST461 have been isolated from patients as well as from corresponding environmental surveillance efforts (32, 33, 51). Moreover, in a phylogenetic analysis of 73 clinical non-SG1 L. pneumophila isolates in Ontario, which borders Southeast Michigan, SG6 was most prevalent (47%) (35). In a 1990 study in Sweden, SG6 was also the most common non-SG1 L. pneumophila serogroup isolated from Legionnaires’ disease patients (54). In the United States, a 1980–1989 survey of 327 Legionnaires’ disease patients attributed 6.4% of disease cases to SG6 L. pneumophila, second only to SG1 (62%). However, the 64% mortality rate of patients with SG6 infection exceeded that for patients infected with SG1 L. pneumophila (37%), even after controlling for specific underlying conditions, age, nosocomial acquisition, and other risk factors (39). On the other hand, a 2013 laboratory analysis discovered that the SG6 L. pneumophila Thunder Bay strain replicates more efficiently in Acanthamoeba castellanii and human monocyte-like cells than SG1 strains yet is more sensitive to killing by the innate immune system’s alternative complement pathway (35). In a mouse model of infection, these SG1 and SG6 strains replicate to similar numbers in the lung, but the SG6 Thunder Bay strain was less proficient at disseminating into the blood and other tissues (35). Accordingly, infection and replication in cultured mouse macrophages may not accurately predict virulence in human lung.
Other key unanswered questions concern L. pneumophila fitness in water and aerosols, the major route of human infection. It is not known whether survival in water aerosols by SG6 L. pneumophila is comparable to that of SG1 strains, whose unusual LPS includes a lipid A moiety that is especially hydrophobic (55). Since the LPS of SG1 L. pneumophila also contributes to lysosome evasion (36), SG1 and -6 strains may differ in their capacities to survive within phagocytic protozoa, their natural predators (56).
Because the widely applied urinary antigen test is specific for SG1 L. pneumophila (42), Legionnaires’ disease due to SG6 and other non-SG1 strains is more difficult to diagnose. Compared to the 60 to 80% sensitivity of the urinary antigen test, the sensitivity of respiratory specimen culture methods ranges from 20 to 80% (57). Furthermore, obtaining sputum specimens from pneumonia patients is challenging, and diagnosis by culture takes several days, requires specialized media and trained personnel, and is hindered by prior empirical treatment with antibiotics (7, 57). Consequently, <5% to 12% of Legionnaires’ disease cases in Europe and the United States are confirmed by culture (4, 5, 9). Instead, urinary antigen testing has been enlisted to confirm diagnosis of >90% of Legionnaires’ disease cases in both the United States and Europe (7, 9). Indeed, although pneumonia due to non-SG1 L. pneumophila likely accounts for >10% of total Legionnaires’ disease incidence (51), it is generally understood that non-SG1 cases are underdiagnosed and underreported (3, 7, 9, 10). In Flint’s Genesee County in 2014 to 2015, the average number of deaths due to pneumonia increased 43% above the average of the previous 5 years; in contrast, pneumonia deaths across Michigan increased only 6% above the state’s 5-year average (58). During this period in Southeast Michigan, it was extremely rare that a Legionnaires’ disease case that was negative by the urinary antigen test was also analyzed by either culture or direct fluorescence antibody testing, and none were analyzed by serology or PCR. Accordingly, during the 2014–2015 Genesee County outbreak, there is no clinical microbiology laboratory evidence of Legionnaires’ disease due to non-serogroup 1 L. pneumophila. Whether SG6 L. pneumophila strains present in Flint premise plumbing contributed to the 2014–2015 increase in pneumonia in Genesee County could be investigated by an epidemiological study that incorporates serological testing for SG6-specific antibodies in patients with community-acquired pneumonia of unknown etiology. Until rapid, sensitive tests are developed to identify and type non-SG1 strains of L. pneumophila, clinicians and public health professionals must rely on culture-based methods to identify cases or sources of Legionnaires’ disease, a critical step in protecting the public from this illness, the most common associated with drinking water in the United States.

MATERIALS AND METHODS

Environmental surveillance.

To evaluate the prevalence of legionellae in Flint premise plumbing, of the 187 total residences enrolled in the study, 130 were sampled and their water cultured according to the protocol described here. The majority (127) of homes were selected at random from Genesee County from tax parcel records; three other residences were selected from a list of potential self-identified participants, with preference given to residents based on perceived risk of acquiring Legionnaires’ disease. Once residences were selected, institutional review board (IRB)-approved recruitment letters were mailed to each property. Within 2 weeks, study personnel knocked on residents’ doors and attempted to obtain informed consent. If consent was obtained, a three-person team returned to collect environmental samples, complete an epidemiological survey focused on legionellosis risk factors, perform a psychosocial needs and resilience assessment, and provide referrals to social services if necessary.
From these 130 residences, a total of 357 water and biofilm samples were collected. At each location, when possible, 2-liter water samples were collected from the hot water tank drain valve, the primary shower used by residents, and the kitchen sink after 5 min of flushing (bypassing point-of-use filters when present). Each 2-liter water sample was collected into polyethylene terephthalate glycol (PETG) bottles containing 0.5 ml of 0.1 N sodium thiosulfate to remove any residual chlorine. After gentle mixing, 125 ml of the aqueous sample was placed in a sterile high-density polyethylene (HDPE) bottle and shipped overnight to Pathogen Control Associates (Peachtree Corners, GA) for culturing. The remaining portion of the 2-liter sample was delivered to Henry Ford Hospital for further analysis (data not shown). To collect shower samples, the shower head was removed prior to the 2-liter first-draw water sample being collected, using hot water only. Once the shower water was collected, a biofilm sample was collected from the shower pipe neck by using a sterile 6-inch swab with a polyester tip, which was then placed in a 15-ml sterile Falcon tube with 5 ml of phosphate-buffered saline (PBS).

Legionella isolation from water samples.

Water samples collected from the residential surveillance operation were cultured for legionellae by Pathogen Control Associates personnel using methods compatible with the relevant CDC laboratory protocol (59) and the International Organization for Standardization 11731:1998 standard (60). To identify suspect colonies to the genus level, colony characteristics were examined microscopically, and their requirement for l-cysteine was tested. To identify candidate isolates to the species and serogroup levels, monovalent and polyvalent direct fluorescent-antibody reagents were used in the direct fluorescence antibody and/or slide agglutination test as described previously (61, 62). To eliminate the risk of experimental bias, premise plumbing samples were cultured by staff of Pathogen Control Associates Laboratories, who then transferred all legionella isolates to the Henry Ford Hospital System for coding, storage, and transfer to the University of Michigan for analysis (Table 1). From each culture-positive premise plumbing sample, only one L. pneumophila isolate was obtained and characterized. Therefore, one limitation of our study is that it cannot address how often residences are colonized by more than one strain of L. pneumophila, as recommended by ISO 11731:1998 (60).

Clinical isolates.

Via a material transfer agreement, the Michigan Department of Health and Human Services Bureau of Laboratories provided 33 clinical isolates submitted from 2013 to 2016 by hospitals in Genesee, Wayne, and Oakland Counties in Michigan (Table 1). All specimens were deidentified prior to shipment to the University of Michigan Medical School.

Laboratory control strains, culture conditions, and reagents.

L. pneumophila strain Philadelphia-1 derivative Lp02, a thymidine auxotroph, served as a previously characterized laboratory reference strain. All L. pneumophila strains were cultured at 37°C in N-(2-acetamido)-2-aminoethanesulfonic acid (ACES; Sigma)-buffered yeast extract broth (AYE); strain Lp02 cultures were supplemented with 100 μg/ml thymidine (T; Sigma). To quantify CFU, aliquots were plated on ACES-buffered charcoal-yeast extract agar (CYE) (63) and incubated at 37°C for 4 days; medium for strain Lp02 was supplemented with 100 μg/ml thymidine. Bacteria obtained from CYE (T) were cultured overnight in AYE (T) and then diluted and cultured overnight to obtain cells in exponential (optical density at 600 nm [OD600] of 1.2 to 1.8) or postexponential (PE) (OD600 of 3.2 to 3.9) phase (64).

Sequence-based typing.

Genotypes were assigned using the sequence-based typing protocol developed by the European Working Group for Legionella Infections (65, 66). Briefly, after extracting genomic DNA from an isolated colony, seven designated gene segments (flaA, pilE, asd, mip, mompS, proA, and neuA) were amplified by PCR. After purification, the DNA products were sequenced using the designated forward and reverse primers (65, 66). To assign allele numbers, each DNA sequence was trimmed in silico by the Legionella SBT quality tool (http://www.hpa-bioinformatics.org.uk/cgi-bin/legionella/sbt/seq_assemble_legionella1.cgi) and then used to query the L. pneumophila database (http://www.hpa-bioinformatics.org.uk/legionella/legionella_sbt/php/sbt_homepage.php). Together, the list of seven assigned allele numbers defines each strain’s numerical sequence type (e.g., ST1). Novel alleles and STs were submitted to the ESGLI database. SBT analysis was performed on deidentified samples at the University of Michigan. Likewise, 33 clinical isolates were deidentified, coded, and shipped by the MDHHS to the University of Michigan for blind SBT analysis.

Serotyping.

The serogroup designations for clinical and environmental isolates initially determined by clinical and commercial laboratories, respectively, were verified by immunolocalization of cell-associated bacteria 1 h after inoculation of mouse macrophage cultures using fluorescein isothiocyanate (FITC)-labeled serotype-specific antibodies. An L. pneumophila SG1-specific rabbit polyclonal antibody (Pierce PA1-73140) was diluted 1:1,000, and an L. pneumophila SG6-specific antibody (prepared by the CDC and a gift of Paul Edelstein of the University of Pennsylvania School of Medicine) was diluted 1:200. All bacteria and macrophages were visualized by staining their DNA with DAPI (4′6-diamidino-2-phenylindole) (not shown).

Phylogenetic analysis.

Phylogenetic relationships among the 18 environmental and 33 clinical L. pneumophila isolates were evaluated using the v3 eBURST online tool (http://eburst.mlst.net/). We defined a clonal complex as strains of those STs that share at least four of the seven alleles with at least one other member of the group.

Immunofluorescence microscopy.

Microscopy was performed by culturing 2.5 × 105 macrophages on 12-mm glass coverslips overnight prior to infection with PE-phase bacteria at a multiplicity of infection of 1. After the infection period, cultures were fixed and stained as described previously (41) using an L. pneumophila SG1-specific rabbit polyclonal antibody conjugated to FITC (Pierce; PA1-73140), which was diluted 1:1,000, and the FITC-conjugated L. pneumophila SG6-specific antibody (prepared by the CDC and a gift of Paul Edelstein), which was diluted 1:200. All bacteria and macrophages were identified by labeling them with the DNA stain DAPI, which was purchased as ProLong Gold antifade reagent (Molecular Probes) and included in the mounting medium.

Serum sensitivity.

To quantify the sensitivity of L. pneumophila to human complement, human serum was purchased (Fisher Scientific; BP2657, lot 174248) and stored at −20°C. As a negative control, complement was heat inactivated by incubating an aliquot of serum at 56°C for 30 min just before use. PE-phase L. pneumophila cells (OD600, 3.5 to 4.1) were collected by centrifugation of 600-μl culture aliquots at 5,000 rpm for 5 min, washed once with 1 ml of PBS, and resuspended in 0.5 ml of PBS. After dilution of duplicate 75-μl cell aliquots into 5 ml of PBS, 50 μl of cells was diluted into 450 μl of nonimmune or heat-inactivated human serum to achieve a final concentration of approximately 5 × 106 cells per ml of 90% serum. After a static incubation at 37°C for 90 to 120 min, cells were serially diluted in PBS and then plated in duplicate on CYE to enumerate CFU. In parallel, the CFU of each untreated inoculum was enumerated after serial dilution of duplicate aliquots. For each strain, the percent survival was calculated as (CFU in serum/CFU in inoculum) × 100 from the mean of results from at least six aliquots per experiment in 2 to 4 independent experiments.

Intracellular growth.

The growth of L. pneumophila strains in bone marrow-derived macrophages from A/J mice (Jackson Laboratories) was assessed by enumerating CFU on CYE (T) medium essentially as described previously (67). PE-phase wild-type Lp01 and dotA mutant cells served as positive and negative controls, respectively. Shown are means ± standard deviations (SD) calculated from triplicate cell preparations. The sequence type, serogroup, and origin of each strain are indicated in Table 1.

ACKNOWLEDGMENTS

We are grateful for the contributions of Joanne Smith-Darden, Mark Zervos, Lara Treemore-Spears, Mary Beth Perri, and other members of the Flint Area Community Health and Environment Partnership, whose surveillance efforts and laboratory assistance were a foundation for this study.
Our work was supported by the Michigan Department of Health & Human Services (MDHHS) under contract number 20163753-00.
As contractually mandated, the manuscript was submitted to the MDHHS for review more than 30 days in advance of being submitted for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the MDHHS.

Footnote

This article is a direct contribution from a Fellow of the American Academy of Microbiology.

REFERENCES

1.
Beer KD, Gargano JW, Roberts VA, Reses HE, Hill VR, Garrison LE, Kutty PK, Hilborn ED, Wade TJ, Fullerton KE, Yoder JS. 2015. Outbreaks associated with environmental and undetermined water exposures—United States, 2011–2012. MMWR Morb Mortal Wkly Rep 64:849–851.
2.
van Heijnsbergen E, Schalk JA, Euser SM, Brandsema PS, den Boer JW, de Roda Husman AM. 2015. Confirmed and potential sources of Legionella reviewed. Environ Sci Technol 49:4797–4815.
3.
Mercante JW, Winchell JM. 2015. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev 28:95–133.
4.
Hicks LA, Garrison LE, Nelson GE, Hampton LM. 2012. Legionellosis—United States, 2000–2009. Am J Transplant 12:250–253. 22244124.
5.
European Centre for Disease Prevention and Control. 2016. Legionnaires’ disease in Europe, 2014. ECDC, Stockholm, Sweden.
6.
Peci A, Winter AL, Gubbay JB. 2016. Evaluation and comparison of multiple test methods, including real-time PCR, for Legionella detection in clinical specimens. Front Public Health 4:175.
7.
Jarraud S, Descours G, Ginevra C, Lina G, Etienne J. 2013. Identification of legionella in clinical samples. Methods Mol Biol 954:27–56. 23150388.
8.
Khodr A, Kay E, Gomez-Valero L, Ginevra C, Doublet P, Buchrieser C, Jarraud S. 2016. Molecular epidemiology, phylogeny and evolution of Legionella. Infect Genet Evol 43:108–122.
9.
Dooling KL, Toews KA, Hicks LA, Garrison LE, Bachaus B, Zansky S, Carpenter LR, Schaffner B, Parker E, Petit S, Thomas A, Thomas S, Mansmann R, Morin C, White B, Langley GE. 2015. Active bacterial core surveillance for legionellosis—United States, 2011–2013. MMWR Morb Mortal Wkly Rep 64:1190–1193.
10.
Cunha BA, Burillo A, Bouza E. 2016. Legionnaires’ disease. Lancet 387:376–385.
11.
Falkinham JO, III, Hilborn ED, Arduino MJ, Pruden A, Edwards MA. 2015. Epidemiology and ecology of opportunistic premise plumbing pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa. Environ Health Perspect 123:749–758.
12.
Taylor M, Ross K, Bentham R. 2009. Legionella, protozoa, and biofilms: interactions within complex microbial systems. Microb Ecol 58:538–547.
13.
Thomas V, Bouchez T, Nicolas V, Robert S, Loret JF, Lévi Y. 2004. Amoebae in domestic water systems: resistance to disinfection treatments and implication in Legionella persistence. J Appl Microbiol 97:950–963.
14.
Donlan RM, Forster T, Murga R, Brown E, Lucas C, Carpenter J, Fields B. 2005. Legionella pneumophila associated with the protozoan Hartmannella vermiformis in a model multi-species biofilm has reduced susceptibility to disinfectants. Biofouling 21:1–7.
15.
Dupuy M, Mazoua S, Berne F, Bodet C, Garrec N, Herbelin P, Ménard-Szczebara F, Oberti S, Rodier MH, Soreau S, Wallet F, Héchard Y. 2011. Efficiency of water disinfectants against Legionella pneumophila and Acanthamoeba. Water Res 45:1087–1094.
16.
Storey MV, Ashbolt J, Stenström TA. 2004. Biofilms, thermophilic amoebae and Legionella pneumophila—a quantitative risk assessment for distributed water. Water Sci Technol 50:77–82.
17.
Cervero-Aragó S, Rodríguez-Martínez S, Puertas-Bennasar A, Araujo RM. 2015. Effect of common drinking water disinfectants, chlorine and heat, on free Legionella and amoebae-associated Legionella. PLoS One 10:e0134726.
18.
Kozak-Muiznieks NA, Lucas CE, Brown E, Pondo T, Taylor TH, Jr., Frace M, Miskowski D, Winchell JM. 2014. Prevalence of sequence types among clinical and environmental isolates of Legionella pneumophila serogroup 1 in the United States from 1982 to 2012. J Clin Microbiol 52:201–211.
19.
Silk BJ, Moore MR, Bergtholdt M, Gorwitz RJ, Kozak NA, Tha MM, Brown EW, Winchester JL, Labus BJ, Rowley P, Middaugh JP, Fields BS, Hicks LA. 2012. Eight years of Legionnaires’ disease transmission in travellers to a condominium complex in Las Vegas, Nevada. Epidemiol Infect 140:1993–2002.
20.
Cowgill KD, Lucas CE, Benson RF, Chamany S, Brown EW, Fields BS, Feikin DR. 2005. Recurrence of Legionnaires disease at a hotel in the United States Virgin Islands over a 20-year period. Clin Infect Dis 40:1205–1207.
21.
Perola O, Kauppinen J, Kusnetsov J, Kärkkäinen UM, Lück PC, Katila ML. 2005. Persistent Legionella pneumophila colonization of a hospital water supply: efficacy of control methods and a molecular epidemiological analysis. APMIS 113:45–53.
22.
Kool JL, Fiore AE, Kioski CM, Brown EW, Benson RF, Pruckler JM, Glasby C, Butler JC, Cage GD, Carpenter JC, Mandel RM, England B, Breiman RF. 1998. More than 10 years of unrecognized nosocomial transmission of Legionnaires’ disease among transplant patients. Infect Control Hosp Epidemiol 19:898–904.
23.
Lepine LA, Jernigan DB, Butler JC, Pruckler JM, Benson RF, Kim G, Hadler JL, Cartter ML, Fields BS. 1998. A recurrent outbreak of nosocomial legionnaires’ disease detected by urinary antigen testing: evidence for long-term colonization of a hospital plumbing system. Infect Control Hosp Epidemiol 19:905–910.
24.
Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL, Legionella Study Group. 2007. Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect Control Hosp Epidemiol 28:818–824.
25.
Mérault N, Rusniok C, Jarraud S, Gomez-Valero L, Cazalet C, Marin M, Brachet E, Aegerter P, Gaillard JL, Etienne J, Herrmann JL, DELPH-I Study Group, Lawrence C, Buchrieser C. 2011. Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples. Appl Environ Microbiol 77:1708–1717.
26.
Nelson R. 2016. Crisis in Flint: lead and Legionnaires’ disease. Lancet Infect Dis 16:298–299.
27.
Masten SJ, Davies SH, McElmurry SP. 2016. Flint water crisis: what happened and why? J Am Water Works Assoc 108:22–34.
28.
Alary M, Joly JR. 1991. Risk factors for contamination of domestic hot water systems by legionellae. Appl Environ Microbiol 57:2360–2367.
29.
Lück C, Fry NK, Helbig JH, Jarraud S, Harrison TG. 2013. Typing methods for legionella. Methods Mol Biol 954:119–148.
30.
Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186:1518–1530.
31.
Pancer K. 2013. Sequence-based typing of Legionella pneumophila strains isolated from hospital water distribution systems as a complementary element of risk assessment of legionellosis in Poland. Ann Agric Environ Med 20:436–440.
32.
Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, Shahar T, Anis E, Valinsky L, Harrison TG, Grotto I, ESCMID Study Group for Legionella Infections (ESGLI). 2014. Molecular epidemiology of Legionnaires’ disease in Israel. Clin Microbiol Infect 20:690–696.
33.
Sánchez-Busó L, Coscollà M, Palero F, Camaró ML, Gimeno A, Moreno P, Escribano I, López Perezagua MM, Colomina J, Vanaclocha H, González-Candelas F. 2015. Geographical and temporal structures of Legionella pneumophila sequence types in Comunitat Valenciana (Spain), 1998 to 2013. Appl Environ Microbiol 81:7106–7113.
34.
Horwitz MA, Silverstein SC. 1981. Interaction of the Legionnaires’ disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med 153:386–397.
35.
Khan MA, Knox N, Prashar A, Alexander D, Abdel-Nour M, Duncan C, Tang P, Amatullah H, Dos Santos CC, Tijet N, Low DE, Pourcel C, Van Domselaar G, Terebiznik M, Ensminger AW, Guyard C. 2013. Comparative genomics reveal that host-innate immune responses influence the clinical prevalence of Legionella pneumophila serogroups. PLoS One 8:e67298.
36.
Fernandez-Moreira E, Helbig JH, Swanson MS. 2006. Membrane vesicles shed by Legionella pneumophila inhibit fusion of phagosomes with lysosomes. Infect Immun 74:3285–3295.
37.
García-Fulgueiras A, Navarro C, Fenoll D, García J, González-Diego P, Jiménez-Buñuales T, Rodriguez M, Lopez R, Pacheco F, Ruiz J, Segovia M, Balandrón B, Pelaz C. 2003. Legionnaires’ disease outbreak in Murcia, Spain. Emerg Infect Dis 9:915–921.
38.
Rao C, Guyard C, Pelaz C, Wasserscheid J, Bondy-Denomy J, Dewar K, Ensminger AW. 2016. Active and adaptive Legionella CRISPR-Cas reveals a recurrent challenge to the pathogen. Cell Microbiol 18:1319–1338.
39.
Marston BJ, Lipman HB, Breiman RF. 1994. Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. Arch Intern Med 154:2417–2422.
40.
Horwitz MA, Silverstein SC. 1980. Legionnaires’ disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest 66:441–450.
41.
Byrne B, Swanson MS. 1998. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect Immun 66:3029–3034.
42.
Helbig JH, Uldum SA, Lück PC, Harrison TG. 2001. Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella urinary enzyme immunoassay (EIA) and Biotest Legionella Urin antigen EIA. J Med Microbiol 50:509–516.
43.
Qin T, Zhou H, Ren H, Guan H, Li M, Zhu B, Shao Z. 2014. Distribution of sequence-based types of Legionella pneumophila serogroup 1 strains isolated from cooling towers, hot springs, and potable water systems in China. Appl Environ Microbiol 80:2150–2157.
44.
David S, Rusniok C, Mentasti M, Gomez-Valero L, Harris SR, Lechat P, Lees J, Ginevra C, Glaser P, Ma L, Bouchier C, Underwood A, Jarraud S, Harrison TG, Parkhill J, Buchrieser C. 2016. Multiple major disease-associated clones of Legionella pneumophila have emerged recently and independently. Genome Res 26:1555–1564.
45.
Cassier P, Campese C, Le Strat Y, Che D, Ginevra C, Etienne J, Jarraud S. 2015. Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France. New Microbes New Infect 3:29–33.
46.
Harrison TG, Afshar B, Doshi N, Fry NK, Lee JV. 2009. Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000–2008). Eur J Clin Microbiol Infect Dis 28:781–791.
47.
David S, Afshar B, Mentasti M, Ginevra C, Podglajen I, Harris SR, Chalker VJ, Jarraud S, Harrison TG, Parkhill J. 2017. Seeding and establishment of Legionella pneumophila in hospitals: implications for genomic investigations of nosocomial Legionnaires’ disease. Clin Infect Dis 64:1251–1259.
48.
Tijet N, Tang P, Romilowych M, Duncan C, Ng V, Fisman DN, Jamieson F, Low DE, Guyard C. 2010. New endemic Legionella pneumophila serogroup I clones, Ontario, Canada. Emerg Infect Dis 16:447–454.
49.
Knox NC, Weedmark KA, Conly J, Ensminger AW, Hosein FS, Drews SJ, Legionella Outbreak Investigative Team. 2017. Unusual Legionnaires’ outbreak in cool, dry Western Canada: an investigation using genomic epidemiology. Epidemiol Infect 145:254–265.
50.
Dutka BJ, Ewan P. 1983. First isolation of Legionella pneumophila from the Canadian Great Lakes. J Gr Lakes Res 9:430–432.
51.
Katsiaflaka A, Pournaras S, Kristo I, Mouchtouri VA, Kyritsi M, Velonakis E, Vatopoulos AC, Hadjichristodoulou C. 2016. Epidemiological investigation of Legionella pneumophila serogroup 2 to 14 isolates from water samples by amplified fragment length polymorphism and sequence-based typing and detection of virulence traits. Appl Environ Microbiol 82:6102–6108.
52.
Doleans A, Aurell H, Reyrolle M, Lina G, Freney J, Vandenesch F, Etienne J, Jarraud S. 2004. Clinical and environmental distributions of Legionella strains in France are different. J Clin Microbiol 42:458–460.
53.
Fendukly F, Bernander S, Hanson HS. 2007. Nosocomial Legionnaires’ disease caused by Legionella pneumophila serogroup 6: implication of the sequence-based typing method (SBT). Scand J Infect Dis 39:213–216.
54.
Bernander S, Kallings I, Nordström K. 1990. Legionella infections diagnosed among hospitalized patients in Västmanland. Lakartidningen 87:4429–4431.
55.
Otten S, Iyer S, Johnson W, Montgomery R. 1986. Serospecific antigens of Legionella pneumophila. J Bacteriol 167:893–904.
56.
Boamah DK, Zhou GQ, Ensminger AW, O’Connor TJ. 2017. From many hosts, one accidental pathogen: the diverse protozoan hosts of Legionella. Front Cell Infect Microbiol 7:477.
57.
Centers for Disease Control and Prevention. 2011. Legionellosis—United States, 2000–2009. Morb Mortal Wkly Rep 60:1083–1086.
58.
Dawsey CP. 26 January 2017. Soaring pneumonia deaths in Genesee County likely linked to undiagnosed Legionnaires’, experts say. Bridge 2017. The Center for Michigan, Ann Arbor, MI. http://www.bridgemi.com/children-families/soaring-pneumonia-deaths-genesee-county-likely-linked-undiagnosed-legionnaires.
59.
Centers for Disease Control and Prevention. 2005. Procedures for the recovery of Legionella from the environment. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, GA. https://www.cdc.gov/legionella/health-depts/inv-tools-cluster/lab-inv-tools/procedures-manual.html.
60.
International Organization for Standardization. 1998. ISO 11731:1998. Water quality—detection and enumeration of Legionella. International Organization for Standardization, Geneva, Switzerland.
61.
Benson RF, Fields BS. 1998. Classification of the genus Legionella. Semin Respir Infect 13:90–99.
62.
Thacker WL, Plikaytis BB, Wilkinson HW. 1985. Identification of 22 Legionella species and 33 serogroups with the slide agglutination test. J Clin Microbiol 21:779–782.
63.
Feeley JC, Gibson RJ, Gorman GW, Langford NC, Rasheed JK, Mackel DC, Baine WB. 1979. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol 10:437–441.
64.
Hammer BK, Swanson MS. 1999. Co-ordination of Legionella pneumophila virulence with entry into stationary phase by ppGpp. Mol Microbiol 33:721–731.
65.
Gaia V, Fry NK, Afshar B, Lück PC, Meugnier H, Etienne J, Peduzzi R, Harrison TG. 2005. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol 43:2047–2052.
66.
Ratzow S, Gaia V, Helbig JH, Fry NK, Lück PC. 2007. Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains. J Clin Microbiol 45:1965–1968.
67.
Swanson MS, Isberg RR. 1995. Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect Immun 63:3609–3620.

Information & Contributors

Information

Published In

cover image mBio
mBio
Volume 9Number 17 March 2018
eLocator: 10.1128/mbio.00016-18
Editor: Howard A. Shuman, University of Chicago
PubMed: 29437918

History

Received: 4 January 2018
Accepted: 9 January 2018
Published online: 6 February 2018

Keywords

  1. Flint water crisis
  2. Legionnaires' disease
  3. intracellular pathogen
  4. macrophages
  5. outbreak

Contributors

Authors

Brenda G. Byrne
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
Sarah McColm
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
Shawn P. McElmurry
Department of Civil and Environmental Engineering, Wayne State University, Detroit, Michigan, USA
Department of Pharmacy Practice, Wayne State University, Detroit, Michigan, USA
Joanne Sobeck
School of Social Work, Wayne State University, Detroit, Michigan, USA
Rick Sadler
Department of Family Medicine, Michigan State University, Flint, Michigan, USA
Nancy G. Love
Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, Michigan, USA
Michele S. Swanson
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA

Editor

Howard A. Shuman
Editor
University of Chicago

Reviewers

Alexander Ensminger
Solicited external reviewer
University of Toronto
Sophie Jarraud
Solicited external reviewer
Laboratoire de Bacterologie, INSERM E0230

Notes

Address correspondence to Michele S. Swanson, [email protected].

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures

Tables

Media

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy